Your browser doesn't support javascript.
loading
Adoption of high-sensitivity cardiac troponin for risk stratification of patients with suspected myocardial infarction: a multicentre cohort study.
McDermott, Michael; Kimenai, Dorien M; Anand, Atul; Huang, Zen; Houston, Andrew; Williams, Sophie; Evison, Felicity; Gallier, Suzy; Carenzo, Catalina; Glampson, Ben; Hasan, Madina; Robertson, Alexander; Phillips, Thomas; Davis, Cai; Sapey, Elizabeth; Mayer, Erik; Mason, Suzanne; Stammers, Matthew; Mills, Nicholas L.
Afiliação
  • McDermott M; British Heart Foundation (BHF) Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Kimenai DM; British Heart Foundation (BHF) Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Anand A; British Heart Foundation (BHF) Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Huang Z; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Houston A; Bart's Health Life Science, Bart's Health NHS Trust, London, UK.
  • Williams S; Bart's Health Life Science, Bart's Health NHS Trust, London, UK.
  • Evison F; PIONEER Health Data Hub and NIHR Birmingham Biomedical Research Centre, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Gallier S; PIONEER Health Data Hub and NIHR Birmingham Biomedical Research Centre, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Carenzo C; Imperial Clinical Analytics, Research & Evaluation (iCARE) Secure Data Environment, NIHR Imperial Biomedical Research Centre, St Mary's Hospital, London, UK.
  • Glampson B; Imperial Clinical Analytics, Research & Evaluation (iCARE) Secure Data Environment, NIHR Imperial Biomedical Research Centre, St Mary's Hospital, London, UK.
  • Hasan M; CURE Group, Sheffield Centre for Health and Related Research, The University of Sheffield, Sheffield, UK.
  • Robertson A; CURE Group, Sheffield Centre for Health and Related Research, The University of Sheffield, Sheffield, UK.
  • Phillips T; Research Data Sciences Team, SETT Centre, University Hospital Southampton, Southampton, UK.
  • Davis C; Research Data Sciences Team, SETT Centre, University Hospital Southampton, Southampton, UK.
  • Sapey E; PIONEER Health Data Hub and NIHR Birmingham Biomedical Research Centre, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Mayer E; Imperial Clinical Analytics, Research & Evaluation (iCARE) Secure Data Environment, NIHR Imperial Biomedical Research Centre, St Mary's Hospital, London, UK.
  • Mason S; CURE Group, Sheffield Centre for Health and Related Research, The University of Sheffield, Sheffield, UK.
  • Stammers M; Research Data Sciences Team, SETT Centre, University Hospital Southampton, Southampton, UK.
  • Mills NL; British Heart Foundation (BHF) Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Lancet Reg Health Eur ; 43: 100960, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38975590
ABSTRACT

Background:

Guidelines recommend high-sensitivity cardiac troponin to risk stratify patients with possible myocardial infarction and identify those eligible for discharge. Our aim was to evaluate adoption of this approach in practice and to determine whether effectiveness and safety varies by age, sex, ethnicity, or socioeconomic deprivation status.

Methods:

A multi-centre cohort study was conducted in 13 hospitals across the United Kingdom from November 1st, 2021, to October 31st, 2022. Routinely collected data including high-sensitivity cardiac troponin I or T measurements were linked to outcomes. The primary effectiveness and safety outcomes were the proportion discharged from the Emergency Department, and the proportion dead or with a subsequent myocardial infarction at 30 days, respectively. Patients were stratified using peak troponin concentration as low (<5 ng/L), intermediate (5 ng/L to sex-specific 99th percentile), or high-risk (>sex-specific 99th percentile).

Findings:

In total 137,881 patients (49% [67,709/137,881] female) were included of whom 60,707 (44%), 42,727 (31%), and 34,447 (25%) were stratified as low-, intermediate- and high-risk, respectively. Overall, 65.8% (39,918/60,707) of low-risk patients were discharged from the Emergency Department, but this varied from 26.8% [2200/8216] to 93.5% [918/982] by site. The safety outcome occurred in 0.5% (277/60,707) and 11.4% (3917/34,447) of patients classified as low- or high-risk, of whom 0.03% (18/60,707) and 1% (304/34,447) had a subsequent myocardial infarction at 30 days, respectively. A similar proportion of male and female patients were discharged (52% [36,838/70,759] versus 54% [36,113/67,109]), but discharge was more likely if patients were <70 years old (61% [58,533/95,227] versus 34% [14,428/42,654]), from areas of low socioeconomic deprivation (48% [6697/14,087] versus 43% [12,090/28,116]) or were black or asian compared to caucasian (62% [5458/8877] and 55% [10,026/18,231] versus 46% [35,138/75,820]).

Interpretation:

Despite high-sensitivity cardiac troponin correctly identifying half of all patients with possible myocardial infarction as being at low risk, only two-thirds of these patients were discharged. Substantial variation in the discharge of patients by age, ethnicity, socioeconomic deprivation, and site was observed identifying important opportunities to improve care.

Funding:

UK Research and Innovation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article